Abiopharma

Inogen Announces Second Quarter 2025 Financial Results

New Form SCHEDULE 13G/A - Chemomab Therapeutics Ltd. Filed: 2025-08-07 AccNo: 0000895421-25-000497 Size: 12 KB

New Form SCHEDULE 13G/A - COHERENT CORP. Filed: 2025-08-07 AccNo: 0000914208-25-000301 Size: 7 KB

New Form 3 - 180 Life Sciences Corp. Filed: 2025-08-07 AccNo: 0001213900-25-073094 Size: 10 KB

New Form 144 - Enliven Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001974158-25-000051 Size: 5 KB

New Form 144 - 180 Life Sciences Corp. Filed: 2025-08-07 AccNo: 0000103623-25-000029 Size: 4 KB

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

New Form 4 - VERTEX PHARMACEUTICALS INC / MA Filed: 2025-08-07 AccNo: 0000875320-25-000218 Size: 6 KB

New Form SCHEDULE 13G/A - Lexeo Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001104659-25-075208 Size: 18 KB

New Form 425 - Gryphon Digital Mining, Inc. Filed: 2025-08-07 AccNo: 0001558370-25-010775 Size: 122 KB

New Form 424B5 - Catheter Precision, Inc. Filed: 2025-08-07 AccNo: 0001437749-25-025439 Size: 15 KB

New Form SCHEDULE 13G/A - BiomX Inc. Filed: 2025-08-07 AccNo: 0000895421-25-000495 Size: 12 KB

New Form 4 - TELEFLEX INC Filed: 2025-08-07 AccNo: 0000096943-25-000127 Size: 4 KB

New Form 4 - BRUKER CORP Filed: 2025-08-07 AccNo: 0001415889-25-021250 Size: 11 KB

New Form 4 - BRUKER CORP Filed: 2025-08-07 AccNo: 0001415889-25-021249 Size: 11 KB